These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32903307)

  • 1. The Anti-inflammatory Effect of Soluble Epoxide Hydrolase Inhibitor and 14, 15-EET in Kawasaki Disease Through PPARγ/STAT1 Signaling Pathway.
    Dai N; Yang C; Fan Q; Wang M; Liu X; Zhao H; Zhao C
    Front Pediatr; 2020; 8():451. PubMed ID: 32903307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular repair and anti-inflammatory effects of soluble epoxide hydrolase inhibitor.
    Dai N; Zhao C; Kong Q; Li D; Cai Z; Wang M
    Exp Ther Med; 2019 May; 17(5):3580-3588. PubMed ID: 30988740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase reduces brain damage and attenuates neuroinflammation after intracerebral hemorrhage.
    Wu CH; Shyue SK; Hung TH; Wen S; Lin CC; Chang CF; Chen SF
    J Neuroinflammation; 2017 Nov; 14(1):230. PubMed ID: 29178914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
    Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
    Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between the Level of Inflammatory Cytokines and Prognosis in Children with IVIG-sensitive Kawasaki Disease and IVIG-resistant Kawasaki Disease.
    Zhang H; Song HB; Wang DX; Deng HY; Sun WL
    Pak J Med Sci; 2022; 38(5):1165-1169. PubMed ID: 35799766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum levels of interleukin-38 and interleukin-1β in the acute phase of Kawasaki disease in children].
    Zhang XY; He T; Ling JY; Hu XF; Wen Y; Wei J; Lu HL
    Zhongguo Dang Dai Er Ke Za Zhi; 2018 Jul; 20(7):543-548. PubMed ID: 30022755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation.
    Fife KL; Liu Y; Schmelzer KR; Tsai HJ; Kim IH; Morisseau C; Hammock BD; Kroetz DL
    J Pharmacol Exp Ther; 2008 Dec; 327(3):707-15. PubMed ID: 18815352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion or inhibition of soluble epoxide hydrolase protects against brain damage and reduces microglia-mediated neuroinflammation in traumatic brain injury.
    Hung TH; Shyue SK; Wu CH; Chen CC; Lin CC; Chang CF; Chen SF
    Oncotarget; 2017 Nov; 8(61):103236-103260. PubMed ID: 29262558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablation of soluble epoxide hydrolase reprogram white fat to beige-like fat through an increase in mitochondrial integrity, HO-1-adiponectin in vitro and in vivo.
    Liu L; Puri N; Raffaele M; Schragenheim J; Singh SP; Bradbury JA; Bellner L; Vanella L; Zeldin DC; Cao J; Abraham NG
    Prostaglandins Other Lipid Mediat; 2018 Sep; 138():1-8. PubMed ID: 30041041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiinflammatory effect of laminar flow: the role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase.
    Liu Y; Zhang Y; Schmelzer K; Lee TS; Fang X; Zhu Y; Spector AA; Gill S; Morisseau C; Hammock BD; Shyy JY
    Proc Natl Acad Sci U S A; 2005 Nov; 102(46):16747-52. PubMed ID: 16267130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
    Qiu Y; Wu J; Fang XY; Lin Z; Wu BY; Cai RY; Xu XY; Zheng H
    Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):688-92. PubMed ID: 15482673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Effects of sEH Inhibitors on the Proliferation and Migration of Vascular Smooth Muscle Cells.
    Kim HS; Kim SK; Kang KW
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29232926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido)-dodecanoic acid, represses human aortic smooth muscle cell proliferation and migration by regulating cell death pathways via the mTOR signaling.
    Li SH; Zhao P; Tian HB; Chen LH; Cui LQ
    Int J Clin Exp Pathol; 2017; 10(8):8434-8442. PubMed ID: 31966695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical value of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 for the prediction and early diagnosis of coronary artery lesion in patients with Kawasaki disease].
    Peng Q; Zhou TF; Chen CH; Hua YM; Liu HM; Hong H; Zhang LY; Wu Q
    Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):676-80. PubMed ID: 16191301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of peroxisome proliferator-activated receptor gamma and adiponectin in children with Kawasaki disease.
    Zhang JY; Peng H; Gong ST; Zeng YM; Huang M; Liu PH; Wang LT; Dong GQ
    J Int Med Res; 2021 Mar; 49(3):300060521994925. PubMed ID: 33729859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel mechanism of brain soluble epoxide hydrolase-mediated blood pressure regulation in the spontaneously hypertensive rat.
    Sellers KW; Sun C; Diez-Freire C; Waki H; Morisseau C; Falck JR; Hammock BD; Paton JF; Raizada MK
    FASEB J; 2005 Apr; 19(6):626-8. PubMed ID: 15659536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 17,18-epoxyeicosatetraenoic acid targets PPARγ and p38 mitogen-activated protein kinase to mediate its anti-inflammatory effects in the lung: role of soluble epoxide hydrolase.
    Morin C; Sirois M; Echavé V; Albadine R; Rousseau E
    Am J Respir Cell Mol Biol; 2010 Nov; 43(5):564-75. PubMed ID: 20008283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative Phosphorylation-Mediated E-Selectin Upregulation Is Associated With Endothelia-Monocyte Adhesion in Human Coronary Artery Endothelial Cells Treated With Sera From Patients With Kawasaki Disease.
    Zhang D; Liu L; Yuan Y; Lv T; Huang X; Tian J
    Front Pediatr; 2021; 9():618267. PubMed ID: 33692974
    [No Abstract]   [Full Text] [Related]  

  • 19. Soluble epoxide hydrolase inhibition improves myocardial perfusion and function in experimental heart failure.
    Merabet N; Bellien J; Glevarec E; Nicol L; Lucas D; Remy-Jouet I; Bounoure F; Dreano Y; Wecker D; Thuillez C; Mulder P
    J Mol Cell Cardiol; 2012 Mar; 52(3):660-6. PubMed ID: 22155238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between
    Liu X; Chen Y; Yang Y; Su Z; Wang F; Zhanghuang C; Wu Y; Zhang X
    Front Med (Lausanne); 2023; 10():1193303. PubMed ID: 37575991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.